Site index | Contacts | Help


6 March 2015

Headed by business development manager, Darren Hughes, Howorth’s Biotechnology Division provides a range of equipment that addresses ever-increasing market demands for effective, safe, state-of-the-art patient protection systems.

The company said: “The BioGen™ DVHP™ (Dry Vaporised Hydrogen Peroxide) range of products, and the BioSphere™ Total Containment Protection System, form part of the Howorth portfolio of equipment and services that are extremely well-established in the healthcare and pharmaceutical sectors.

“BioGen™ DVHP™ decontamination is an effective bactericide, fungicide, virucide, and sporicide that provides up to and including a 6 log (106) kill against pathogens such as MRSA and C. difficile.” BioSphere™, meanwhile, is ‘a quick and simple containment solution that provides aesthetic, robust, and highly capable pathogen containment to hospitals and treatment facilities’. “Hospitals can safely contain healthcare-associated infections, and provide absolute biological decontamination in just 24 hours,” Howorth explained.

The BioSphere™ unit creates an individually contained and managed ‘mini-environment’ around each patient care zone, which operates under a negative airflow system designed to contain pathogens and potential sources of HCAI. It combines the visibility of a ward with the containment and privacy of a single room.”